However, a large body of research suggests that other genetic components may also be involved in the manifestation of AD, such as mutations in amyloid-beta precursor protein (AβPP), presenilin1, and presenilin 2 genes attributing to the overproduction of Aβ plaques. Here, APP is linked to Alzheimer disease.